Now that we are in the midst of a pandemic, I thought it would be of interest to post a section of a report I wrote in 2009 which included pandemics. Given the date, you should assume the science is… Read More »Think like a virus: pandemic preparedness
This is another article in my continuing commentary on market access and politics. The focus in this case is to look more closely at behaviours of people involved from government, industry and healthcare. Occupying these roles are people who bring… Read More »Behavioural economics: payer psychology and market access
The relevance of value in establishing the positioning of medicines is the new normal for pharmaceutical marketing. Pharmaceutical companies have customers who are highly constrained by whether healthcare system funding is sustainable long term. Remember, payers think epidemiologically and in… Read More »Positioning drugs in markets: how payers determine value